What is the most likely stage I am at

Bladder CancerApril 29, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Estimating Your Most Likely Stage: Clinical Analysis

Based on the clinical details you've provided, let me walk through the statistical likelihood of your stage. However, I must emphasize: your actual stage can only be definitively determined by your pathology report after TURBT (Transurethral Resection of Bladder Tumor).


YOUR CLINICAL PRESENTATION SUMMARY

Let me organize what we know:

| Factor | Your Status | Prognostic Significance | |---|---|---| | Tumor size | 3 cm | Moderate-sized (increases muscle invasion risk) | | Location | Bladder base | Higher-risk anatomical site | | Hydronephrosis | Absent | Favorable (no upper tract obstruction) | | Age | 50 years | Good treatment tolerance | | Overall health | Healthy | Good surgical/chemotherapy candidate | | Smoking status | Non-smoker | Favorable prognostic factor |


STATISTICAL LIKELIHOOD BY STAGE

Overall Bladder Cancer Distribution

According to epidemiologic data and the NCCN Guidelines for Bladder Cancer, approximately:

  • 70-75% of newly diagnosed bladder cancers are non-muscle-invasive (Ta, T1, Tis)
  • 25-30% are muscle-invasive (T2 or higher)

Your Specific Risk Stratification

Given your 3 cm tumor at the bladder base, here's my evidence-based estimate:

Most Likely Scenario: Non-Muscle-Invasive Disease (55-65% probability)

This would include:

  • Ta (confined to mucosa) — ~20-25% probability
  • T1 (invades lamina propria) — ~30-40% probability
  • Tis (carcinoma in situ) — ~5-10% probability

Secondary Scenario: Muscle-Invasive Disease (35-45% probability)

This would include:

  • T2a (superficial muscle invasion) — ~20-25% probability
  • T2b (deep muscle invasion) — ~10-15% probability
  • T3 or higher (beyond muscle) — ~5% probability

WHY THESE ESTIMATES?

Factors Favoring Non-Muscle-Invasive (Lower Stage)

Absence of hydronephrosis

  • Suggests the tumor hasn't invaded deeply enough to obstruct ureteral drainage
  • Hydronephrosis is associated with higher-stage disease
  • Your lack of it is a favorable sign

No mention of systemic symptoms

  • Muscle-invasive disease sometimes presents with constitutional symptoms
  • Your presentation appears localized

Overall bladder cancer epidemiology

  • 70-75% of new diagnoses are non-muscle-invasive
  • This is your baseline probability

Factors Increasing Risk of Muscle Invasion (Higher Stage)

⚠️ Tumor size (3 cm)

  • Larger tumors have higher invasion risk
  • Tumors <1 cm: ~10-15% muscle invasion rate
  • Tumors 1-3 cm: ~30-40% muscle invasion rate
  • Tumors >3 cm: ~50-60% muscle invasion rate
  • Your 3 cm tumor is at the threshold where muscle invasion becomes more likely

⚠️ Bladder base location

  • The trigone region (where ureters enter) has slightly higher invasion risk
  • Not as high-risk as dome or anterior wall, but more concerning than lateral wall

⚠️ Tumor appearance (unknown)

  • If your tumor is sessile (flat, broad base) rather than papillary (finger-like projections), muscle invasion risk increases significantly
  • Your urologist should have documented this appearance

WHAT YOUR PATHOLOGY REPORT WILL REVEAL

Your definitive stage depends on these pathology findings:

Depth of Invasion (Most Important)

MUCOSA (innermost layer)
    ↓
LAMINA PROPRIA (connective tissue)
    ↓
MUSCULARIS (muscle layer)
    ↓
PERIVESICAL FAT (outer layer)

Your pathology will specify:

  • Ta = Confined to mucosa only
  • T1 = Invades lamina propria (but NOT muscle)
  • T2a = Invades superficial muscle
  • T2b = Invades deep muscle
  • T3 = Invades perivesical fat
  • T4 = Invades adjacent organs

Grade (Aggressiveness)

  • Grade 1 (low-grade) = Less aggressive, better prognosis
  • Grade 2 (intermediate-grade) = Moderate aggressiveness
  • Grade 3 (high-grade) = Most aggressive, higher recurrence/progression risk

Important: High-grade tumors are more likely to be muscle-invasive

Other Critical Findings

  • Carcinoma in situ (CIS) — High-risk finding, often associated with muscle invasion
  • Lymphovascular invasion — Cancer in blood/lymph vessels (worse prognosis)
  • Adequacy of resection — Was the entire tumor removed with clear margins?

MOST LIKELY SPECIFIC STAGE PREDICTION

Based on all your factors, here's my best estimate of your most likely stage:

PRIMARY PREDICTION: T1, Grade 2-3 (Non-Muscle-Invasive)

Probability: ~35-40%

Why this is most likely:

  • Fits your 3 cm size (T1 tumors can be this large)
  • Explains absence of hydronephrosis (hasn't invaded deeply)
  • Consistent with your overall health presentation
  • Represents the most common presentation for your tumor size

What this means:

  • Tumor invades the lamina propria but NOT the muscle
  • Requires repeat TURBT at 4-6 weeks to ensure complete resection
  • Intravesical chemotherapy course (6 weekly instillations)
  • Intensive surveillance with cystoscopy every 3 months for 2 years
  • ~30-40% recurrence risk, ~5-10% progression to muscle-invasive disease

SECONDARY PREDICTION: Ta, Grade 2-3 (Non-Muscle-Invasive)

Probability: ~20-25%

Why this is possible:

  • Larger Ta tumors do occur
  • Would explain your good clinical status
  • Better prognosis than T1

What this means:

  • Tumor confined to mucosa only
  • Single-dose intravesical chemotherapy (within 24 hours of TURBT)
  • Cystoscopy surveillance every 3-6 months
  • Lower recurrence risk (~20-30%)

TERTIARY PREDICTION: T2a, Grade 2-3 (Muscle-Invasive)

Probability: ~20-25%

Why this is possible:

  • Your 3 cm size increases muscle invasion risk
  • Bladder base location is higher-risk
  • Still relatively early muscle invasion

What this means:

  • Tumor invades superficial muscle layer
  • Requires neoadjuvant chemotherapy (cisplatin-based) before surgery
  • Followed by radical cystectomy with pelvic lymph node dissection
  • Urinary diversion (ileal conduit, neobladder, or continent pouch)
  • Your non-smoker status and good health are favorable for tolerating this aggressive approach

LESS LIKELY PREDICTIONS

T2b or higher (Deep muscle or beyond): ~10-15% probability

  • Would be concerning but still potentially curable with aggressive treatment
  • Your lack of hydronephrosis makes this less likely

Tis (Carcinoma in situ): ~5% probability

  • Usually presents with irritative symptoms (frequency, urgency)
  • Not typically a 3 cm visible lesion
  • Less likely given your presentation

WHAT HAPPENS AT YOUR TURBT

Your urologist will:

  1. Visually inspect the tumor (papillary vs. sessile appearance)
  2. **

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: